Abstract
This article utilized data from the state registers of registered medications, medical supplies, and medical apparatus in No. 22 of 2018, No. 23 of 2019, No. 24 of 2020, No. 25 of 2021, and No. 26 of 2022 in the Republic of Uzbekistan. On the basis of the received data, a variety of analyses of nootropic medicines registered in the Republic of Uzbekistan were performed.10.47191/ijcsrr/V6-i6-47
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Current Science Research and Review
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
